Literature DB >> 670402

Responsiveness of neoplastic and hyperplastic parathyroid tissues to calcium in vitro.

J F Habener.   

Abstract

Secretory and biosynthetic responses of adenomatous, carcinomatous, and hyperplastic parathyroid tissues to variable concentrations of extracellular calcium were assessed in vitro. Tissues, obtained at the time of parathyroidectomy, were incubated for 4 h in media containing radioactive amino acids and varying (0.5-5.0 mM) concentrations of calcium. Amounts of newly synthesized and total parathyroid hormone and proparathyroid hormone in extracts of tissues and media were measured by polyacrylamide gel electrophoresis and by radioimmunoassay, respectively. All tissues studied (six adenomas, two specimens of chief-cell hyperplasia, one carcinoma, and normal bovine and human glands) responded to changes in calcium concentrations; decreasing concentrations of calcium stimulated release and decreased tissue storage of hormone. Six of the abnormal tissues required greater than normal concentrations of calcium (1.8-2.4 mM for 50% of effect) to elicit secretory responses comparable with those of normal glands (1.4 mM). Maximum effects of calcium on release of hormone varied from 2- to 10-fold among different tissues. Release of some hormone persisted even in concentrations of calcium as high as 5.0 mM. Relative amounts of hormone released from and retained in the tissues varied greatly among the tissues, as did the absolute amounts of hormone produced; newly synthesized, labeled hormone ranged between 0.6 and 12% of total labeled protein, and immunoreactive hormone ranged between 0.015 and 0.9% of total tissue protein. Effects of calcium on hormone biosynthesis, as determined by analyses of amounts of proparathyroid hormone in the tissues, were variable among tissues and in many cases were negligible. These results indicate that neoplastic and hyperplastic parathyroid tissues retain secretory responsiveness to changes in extracellular concentrations of calcium. Responses, however, are highly variable among different tissues, and in many instances are abnormal, inasmuch as greater than normal concentrations of calcium are required to alter release and synthesis of hormone. A combination of both increased mass of glandular tissue and abnormal regulations of hormone secretion appear to contribute to the hypersecretion of hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 670402      PMCID: PMC371782          DOI: 10.1172/JCI109145

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Proparathyroid hormone: identification of a biosynthetic precursor to parathyroid hormone.

Authors:  B Kemper; J F Habener; J T Potts; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

2.  Spectrum of hyperparathyroidism.

Authors:  E Reiss; J M Canterbury
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

3.  Parathyroid secretion: discovery of a major calcium-dependent protein.

Authors:  B Kemper; J F Habener; A Rich; J T Potts
Journal:  Science       Date:  1974-04-12       Impact factor: 47.728

4.  Isolation of human parathyroid hormone.

Authors:  H T Keutmann; P M Barling; G N Hendy; G V Segre; H D Niall; G D Aurbach; J T Potts; J L O'Riordan
Journal:  Biochemistry       Date:  1974-04-09       Impact factor: 3.162

5.  Multiple immunoreactive molecular forms of parathyroid hormone in human serum. 1.

Authors:  J M Canterbury; E Reiss
Journal:  Proc Soc Exp Biol Med       Date:  1972-09

6.  Determination of calcium in urine and serum by atomic absorption spectrophotometry (AAS).

Authors:  D L Trudeau; E F Freier
Journal:  Clin Chem       Date:  1967-02       Impact factor: 8.327

7.  Calcium-regulated parathyroid hormone peptidase.

Authors:  J A Fischer; S B Oldham; G W Sizemore; C D Arnaud
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

8.  Parathyroid Hormone in Human Plasma: IMMUNOCHEMICAL CHARACTERIZATION AND BIOLOGICAL IMPLICATIONS.

Authors:  G V Segre; J F Habener; D Powell; G W Tregear; J T Potts
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

9.  Heterogeneity of parathyroid hormone. Clinical and physiologic implications.

Authors:  R Silverman; R S Yalow
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

10.  Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility.

Authors:  R S Goldsmith; J Furszyfer; W J Johnson; A E Fournier; G W Sizemore; C D Arnaud
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

View more
  4 in total

1.  Differences in PTH (1-84) release in response to ambient calcium concentrations of parathyroid adenoma fragments and dispersed parathyroid adenoma cells in culture.

Authors:  M Yu; H M Van Herle; J D Lin; A E Giuliano; A J Van Herle
Journal:  J Endocrinol Invest       Date:  1996-06       Impact factor: 4.256

2.  Studies on in vivo and in vitro release of intact parathyroid hormone using a new two-site immunochemiluminometric assay.

Authors:  J P Aston; M H Wheeler; R C Brown; I R Curley; J S Woodhead
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

3.  Regulation of parathyroid hormone release and cytosolic calcium by extracellular calcium in dispersed and cultured bovine and pathological human parathyroid cells.

Authors:  M S LeBoff; D Shoback; E M Brown; J Thatcher; R Leombruno; D Beaudoin; M Henry; R Wilson; J Pallotta; S Marynick
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

4.  Vitamin D and hyperparathyroidism: the Lumleian Lecture 1981.

Authors:  S W Stanbury
Journal:  J R Coll Physicians Lond       Date:  1981-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.